Treatment Approaches For Polycystic Ovary Syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a common condition affecting many women with ovaries of reproductive age, but it is not just a young woman’s disease, and it affects people with ovaries of all ages. Symptoms include irregular periods or no menstruation, excess hair, acne, weight problems, and infertility. Treatment options are many, and individualized depending on a woman’s medical history, health goals, and preferences. PCOS is a dynamic condition and the most effective care for women with PCOS includes establishing treatment goals and using stepwise therapies to meet those goals, as well as following patients over time for potential metabolic and mental health consequences.

Why It Matters

PCOS matters. PCOS is not just a reproductive health issue; it affects overall health as well. At first women with PCOS typically notice problems related to their period or fertility. But then they find out that they have insulin resistance or even type 2 diabetes, have trouble loosing weight, have high levels of androgens and have a increased lifetime risk of major metabolic problems. The physical symptoms of PCOS often go hand in hand with emotional symptoms of anxiety and/or depression that can decrease a woman’s overall quality of life. This can even make self care a challenge.

The syndrome PCOS (Polycystic Ovary Syndrome) affects also women with irregular ovulation, in which the uterus is at risk of complications due to the large time intervals between bleeding episodes. Repeated exposure to high levels of estrogen can result in endometrial hyperplasia and cause abnormal uterine bleeding. For women with PCOS who are not desiring children, we can give medication on a continuous basis to induce regular menstrual cycles, or we can administer progesterone on a regular basis to give the uterine lining appropriate exposure to prevent damage.

PCOS is a costly and complex condition for the health care system, requiring long-term, multi disciplinary health care for women with PCOS. In addition to being under the care of a primary care physician for metabolic screening, women with PCOS are under the care of an obstetrician–gynecologist for management of cycle and contraception, an endocrinologist for management of insulin resistance and associated cardiometabolic risks, a dermatologist for management of acne and hirsutism, and reproductive endocrinologist and/or reproductive surgeon for treatment of infertility. Many women with PCOS also benefit from care by mental health professionals and registered dietitians. However, there are significant variations in coordination of care and access to health care services for fertility treatment, weight management programs, medications for PCOS (i.e. birth control pills and hormonal medications for hirsutism and acne) and cosmetic treatments (i.e. hair removal, acne treatment and body contouring).

Treatment options for polycystic ovary syndrome (PCOS) need to be carefully counsel patients and their families as to indications and limitations. Some treatments are best for cycle regulation and control of androgen symptoms (e.g. hirsutism, acne), and are not indicated for women trying to conceive. Fertility focused treatments for PCOS are excellent at restoring ovulation, but are not the best choice for rapid treatment of severe acne or hirsutism, and several anti-androgen medications have been associated with fetal risk, thus reliable contraception and a thorough discussion of risks and benefits is essential prior to initiation of any of these medications. A process of shared decision-making between patient and provider regarding the various options is ideal, taking into consideration both short term goals and long term health outcomes.

Who It Affects

PCOS is commonly believed to affect women of reproductive age who have ovaries, but it can be present at any age. Many women with PCOS are first diagnosed in their teenage years, and they can continue to have symptoms well into their 30s and 40s. Although many women with PCOS receive a proper diagnosis in their teens after years of symptoms, some women can be misdiagnosed or go undiagnosed for even longer. A woman with PCOS can be at a healthy weight and have irregular cycles due to seemingly random circumstances, such as stress.

Differential diagnosis of PCOS in adolescents and young women requires consideration of normal pubertal development. Girls typically experience irregular cycles in the first couple of years post menarche and acne is very common in teenagers. However, when irregular cycles persist into late teens, or are accompanied by features of hyperandrogenism such as hirsutism, acne or biochemical hyperandrogenism, evaluation and appropriate management is indicated. Young patients and their families should feel that treatment of PCOS is focused on relief of symptoms, promotion of healthy lifestyle habits, and optimization of mental health and wellness, without stigmatizing or “blaming” language.

The patients who desire to become pregnant with PCOS require a management approach that is distinct from that of the woman with PCOS who does not wish to become pregnant. Many women are diagnosed with PCOS during the process of their evaluation for infertility to conception. Therefore, in addition to the stepwise approach to ovulation induction as well as appropriate monitoring of ovulation and conception, an understanding of the time frame for conception and counseling as to whether or not partner testing or evaluation for other causes of infertility is indicated is essential so that patients and their physicians do not waste time on an incomplete evaluation.

Early detection and prevention of cardiometabolic disease is an important consideration for individuals who are at risk, including obese individuals as well as those with prediabetes or other risk factors such as family history of type 2 diabetes, history of gestational diabetes, hypertension, dyslipidemia or sleep apnea symptoms. Women with PCOS should be managed as having a chronic medical condition and aggressively monitored for complications of metabolic syndrome, even after the resolution of the reproductive symptoms or fertility concerns.

The present volume is intended to address the clinical information needs of several constancies of position and time, including those of primary health care providers, obstetrician–gynecologists, endocrinologists, and dermatologists. These health care professionals are the first to evaluate women with hyperandrogenic disorders and subsequently be responsible for lifelong tracking of risk for these disorders. This book is intended to be a comprehensive primer to provide all clinicians with a uniform understanding of the causes, consequences, diagnosis, and treatment of these complex disorders. In this respect, primary care physicians and other health care providers are the initial constellations of position in time that are involved in the assessment of women with hyperandrogenic disorders, followed by the obstetrician–gynecologists, endocrinologists, and dermatologists who comprise the subsequent constellations of position and time involved in monitoring these patients. In addition to the reproductive endocrinologists who provide care for ovulation induction and infertility diagnosis and management, patients and families are supported by a team of Dietitians, Exercise Specialists, mental-health clinicians and Pharmacists to make and maintain lifestyle choices which promote health and optimize treatment.

PCOS does not just affect the woman with PCOS; it also affects her family, her employer, policy makers and payers such as health insurance companies. In addition to these obvious stakeholders, there are the treatments for PCOS that will affect health outcomes and daily functioning of women with PCOS. Many of these stakeholders will decide what aspects of PCOS treatment and management will be covered by insurance (fertility care, metabolic care for diabetes and heart disease risk factors, mental health care, weight management). PCOS can also decrease school and work productivity as well as affect caregiving for family members with PCOS.

What Changes

• PCOS treatment works best when care is goal-driven, staged, and revisited over time. The first clinical step is asking what matters most right now: pregnancy, symptom control for hair and acne, cycle regulation and uterine protection, metabolic risk reduction, or quality of life. Goals may change over time, so the plan should be reviewed regularly rather than set once and forgotten.
• Step 1: Confirm the diagnosis and complete a practical baseline assessment. Before starting long-term therapy, clinicians should assess menstrual history, signs of hyperandrogenism, weight and waist measures, and blood pressure, and consider targeted laboratory testing when indicated. It is also important to rule out other causes of irregular cycles or androgen excess. Baseline discussion should include current medications, contraception needs, pregnancy intention, sleep quality, mood symptoms, and eating behaviors. This initial assessment helps tailor treatment and creates a clear starting point for follow-up.

• Step 2: Build a lifestyle foundation that is realistic and non-stigmatizing. Lifestyle interventions remain foundational for most people with PCOS and can improve insulin sensitivity, cardiometabolic risk, and sometimes menstrual regularity. The most effective plan is the one a patient can maintain long term. Clinicians should focus on achievable habits, not perfection. Helpful strategies include consistent meal structure, reducing sugar-sweetened beverages, increasing fiber and protein intake, and prioritizing whole foods when possible. Physical activity should include aerobic movement and resistance training, adjusted to the person’s starting point and constraints. Sleep support and stress reduction matter, because poor sleep and chronic stress can worsen appetite regulation and metabolic risk.
• Step 3: Choose menstrual regulation and uterine protection strategies for those not seeking pregnancy. For people with infrequent or absent periods, the priority is to protect the uterine lining and reduce irregular bleeding. Combined hormonal contraception is commonly used to provide predictable withdrawal bleeding, lower ovarian androgen production, and improve acne over time. If estrogen is not appropriate or not preferred, options include a progestin-releasing intrauterine device or cyclic progestin therapy to provide endometrial protection. The choice should consider blood pressure, migraine history, smoking status, clotting risks, patient preference, and the need for contraception.
• Step 4: Treat androgen-related symptoms with a long view and combination care. Hirsutism and acne often improve slowly. Patients should be counseled to expect several months before meaningful changes are visible, and longer for hair growth changes. Combined hormonal contraception can reduce free androgen levels and may improve acne and hair symptoms over time. If symptoms remain bothersome, anti-androgen medicines may be considered for appropriate patients, but clinicians must counsel clearly about fetal risk and ensure reliable contraception. For acne, topical therapies, oral antibiotics when appropriate, and dermatologic regimens can be useful. For unwanted hair, cosmetic procedures such as laser hair reduction or electrolysis can provide meaningful improvement and may reduce the emotional burden of daily hair removal. These services are often not covered by insurance, so clinicians should discuss realistic access and alternatives.
• Step 5: Address scalp hair thinning with early recognition and supportive planning. Some patients experience androgen-related hair thinning that can worsen gradually. Early dermatology referral may be helpful. Management often focuses on preserving hair density and setting realistic expectations, because regrowth can be slow and sometimes incomplete. Clinicians should also consider other contributors when clinically relevant, such as thyroid disease or iron deficiency, and address them as part of a comprehensive plan.
• Step 6: Add metabolic pharmacotherapy when lifestyle measures are not enough, especially for higher-risk patients. Metformin may be considered for patients with insulin resistance, impaired glucose tolerance, or higher metabolic risk, and it can improve menstrual regularity in some individuals. Side effects such as gastrointestinal discomfort should be discussed, and dosing can be adjusted to improve tolerance. For selected patients with higher body weight and significant cardiometabolic risk, structured weight-management programs and, when appropriate, anti-obesity medications may be considered alongside lifestyle support. These choices require careful counseling about benefits, side effects, cost, access, and pregnancy plans, because some weight-loss medications are not appropriate during pregnancy or when trying to conceive.
• Step 7: Use fertility-focused therapy when pregnancy is the goal. For people seeking pregnancy, the approach shifts toward restoring ovulation and timing conception. A basic infertility evaluation should include assessment of semen factors and tubal status when indicated, so that PCOS is not treated in isolation. For many patients with PCOS, oral ovulation induction can be highly effective and may avoid the need for more invasive treatments at first. Treatment should be coordinated with a clinician experienced in fertility care, and monitoring plans should be used to reduce the risk of multiple pregnancy and guide dosing and timing.
• Step 8: Escalate fertility care stepwise when first-line therapy does not succeed. Some patients will need additional cycles, adjusted dosing, or a switch to different protocols. If oral ovulation induction is not successful, escalation may include injectable gonadotropins with careful monitoring or assisted reproductive technologies depending on age, duration of infertility, and local access. Clinicians should discuss risks such as multiple gestation and ovarian hyperstimulation, along with emotional stress and financial considerations. Supportive counseling and clear timelines can help patients stay engaged and avoid feeling lost in the process.
• Step 9: Integrate mental-health care as routine PCOS care, not an optional add-on. Screening for depression and anxiety should be standard and repeated over time. Counseling, coping strategies, and peer support can reduce distress and improve adherence to lifestyle changes and medication routines. When medication for mood is needed, clinicians should consider pregnancy plans and coordinate care so that mental-health treatment supports, rather than conflicts with, fertility and safety goals.
• Step 10: Make pregnancy counseling explicit whenever medications are prescribed. Because several effective treatments are unsafe in pregnancy, clinicians should ask about pregnancy intention at every visit and document a contraception plan when needed. When patients plan to conceive, medication changes should be made in advance to reduce fetal risk and avoid delays. Clear counseling improves safety and reduces confusion when goals shift from symptom control to conception.
• Step 11: Improve systems of care with coordinated pathways and planned follow-up. Health systems can improve outcomes by creating streamlined referral routes, standardized intake checklists, and follow-up plans that track symptoms, cycles, metabolic markers, and patient goals over time. Telehealth can expand access to nutrition counseling, behavior change support, and medication check-ins. Payers and clinics can improve equity by supporting coverage for lifestyle programs and mental-health services, and by reducing barriers to fertility care when appropriate.

PCOS is a lifelong condition for which management strategies need to be revisited at critical points in a woman’s life. Monitoring of metabolic risk factors, assessment of effect of treatment and reappraisal of reproductive goals in women with PCOS should be an ongoing process.

References:

https://pmc.ncbi.nlm.nih.gov/articles/PMC3737989/ https://pmc.ncbi.nlm.nih.gov/articles/PMC4287252/